Paragraf and INTRATOMICS move graphene biosensor work toward commercial development

Paragraf has signed a memorandum of understanding with INTRATOMICS Advanced Material Technologies to jointly develop graphene-enabled sensor technologies, adding a fresh commercial step to one of the field’s most active application areas. The agreement, announced on October 21, 2025, is aimed at advancing next-generation sensing systems built around graphene electronics and biosensing.

Paragraf’s sensor push reaches a new partner in Abu Dhabi

The UK-based company said the collaboration is designed to pioneer graphene-based sensor technologies with INTRATOMICS, a subsidiary of Khalifa University Enterprises Company. Paragraf described the effort as part of its broader push to commercialize graphene electronics using standard semiconductor processes, an important distinction in a market where many graphene sensor concepts remain at laboratory scale.

The companies did not disclose financial terms, product names or a launch timetable. The immediate value of the agreement is in giving the partners a formal framework to evaluate and develop sensor concepts together rather than separately.

Why the graphene sensor market is watching this kind of deal

Graphene sensors continue to attract attention because the material’s electrical properties can support highly sensitive detection in biosensing, gas sensing and other diagnostic applications. In practice, the commercial hurdle has been turning those lab results into reproducible devices that can be manufactured with semiconductor-style controls and integrated into usable systems.

That makes partnership announcements like this one meaningful even without a finished product. They can signal that a sensor platform has moved far enough along to justify joint development, technical evaluation and potential downstream scaling work.

What Paragraf said about the collaboration

Paragraf said the memorandum of understanding is intended to support development of advanced graphene-enabled sensor solutions. The company has been positioning graphene electronics as a manufacturable platform, and the new agreement extends that effort into a more application-specific collaboration.

For now, the announcement is more about execution than spectacle: a formal research-and-development bridge between a graphene device specialist and a regional advanced-materials partner, with biosensing among the most commercially watched targets in the sector.